Predictive Factors for Relapse in Autoimmune Pancreatitis

Area of Science:

• Gastroenterology
• Immunology
• Oncology

Background:

• Autoimmune pancreatitis (AIP) is an inflammatory pancreatic condition responsive to glucocorticoids.
• Type 1 AIP has a high relapse rate (~40%), unlike type 2 AIP.
• Identifying relapse predictors is crucial for managing AIP.

Purpose of the Study:

• To review factors influencing autoimmune pancreatitis (AIP) relapse, focusing on type 1.
• To synthesize evidence for effective clinical management strategies.

Main Methods:

• Narrative review of current literature on AIP relapse.
• Analysis of serological markers, imaging features, and therapeutic interventions.

Main Results:

• Dynamic serum IgG4 changes (insufficient decline, increase, or persistent elevation) correlate with relapse risk.
• Other potential predictors include immunoglobulin E, autotaxin, imaging findings, and extrapancreatic involvement.
• Prolonged glucocorticoid maintenance reduces relapse; immunosuppressants and rituximab show promise for refractory cases.

Conclusions:

• Serum IgG4 levels, imaging, and extrapancreatic involvement are key indicators for AIP relapse risk.
• Long-term glucocorticoid therapy is effective in preventing relapse.
• Further research into novel therapeutic agents is warranted for refractory autoimmune pancreatitis.